Strengthening Cannabinoid R&D

Controlled Drugs Licensing Reforms
for UK Medical and Scientific
Research in Academia and Industry

Professor Trevor Jones CBE FMed Sci
Zack Bellman

About

Positioned at the heart of the life sciences sector, the Cannabinoid Research & Development Group UK is a new research strategy group led by academics, researchers, clinicians, patients and industry. 

The group will propel scientific research and development of pharmaceutical cannabinoid-related products in the UK.

Our ambition is to develop and implement a comprehensive strategy to transform the UK into the global leader in cannabinoid research and medicine development. 

We will build a robust ecosystem by integrating universities, research institutions, investors, businesses, and the NHS – driving innovation and development, nurturing top talent and fostering advances in healthcare.

Going for Growth George Freeman MP
George Freeman MP at CRDG's Going for Growth launch event, The Royal Society of Medicine, London

Updates and Articles

Archive

The CRDG represents an evolution of The Centre for MC, which formed in November 2019. Our archive includes all reports and papers published by the CDRG and the CMC.

Members

Artelo Biosciences logo

Member Profiles

Contact Us

Membership and general enquiries steve@crdg.uk.

Newsletter

Sign up for CRDG news and updates.